Celgene Corporation to Webcast at Upcoming Investor Conferences and R&D Deep Dive in September
August 29 2016 - 07:30AM
Business Wire
Celgene Corporation (NASDAQ:CELG) plans to present at two
upcoming investor conferences and at an R&D deep dive in
September where Celgene management will provide an overview of the
Company. The conferences and R&D deep dive will be webcast live
and the webcasts will be available in the Investor Relations
section of the Company’s website at www.celgene.com.
Wednesday, September 7, 2016, Celgene will
present at the Citi 11th Annual Biotech Conference in Boston at 12
noon ET
Monday, September 12, 2016, Celgene will
present at the Morgan Stanley Global Healthcare Unplugged
Conference in New York City at 2:50 pm ET
Thursday, September 29, 2016, Celgene will
webcast an R&D Deep Dive on Protein Homeostasis beginning at
1:30pm ET. The webcast is expected to conclude at 5pm ET.
About Celgene
Celgene Corporation, headquartered in Summit, New Jersey, is an
integrated global biopharmaceutical company engaged primarily in
the discovery, development and commercialization of innovative
therapies for the treatment of cancer and inflammatory diseases
through next-generation solutions in protein homeostasis,
immuno-oncology, epigenetics, immunology and neuro-inflammation.
For more information, please visit www.celgene.com. Follow Celgene
on Social Media: @Celgene, Pinterest, LinkedIn, FaceBook and
YouTube.
Forward-Looking Statements
This press release contains forward-looking statements, which
are generally statements that are not historical facts.
Forward-looking statements can be identified by the words
"expects," "anticipates," "believes," "intends," "estimates,"
"plans," "will," “outlook” and similar expressions. Forward-looking
statements are based on management’s current plans, estimates,
assumptions and projections, and speak only as of the date they are
made. We undertake no obligation to update any forward-looking
statement in light of new information or future events, except as
otherwise required by law. Forward-looking statements involve
inherent risks and uncertainties, most of which are difficult to
predict and are generally beyond our control. Actual results or
outcomes may differ materially from those implied by the
forward-looking statements as a result of the impact of a number of
factors, many of which are discussed in more detail in our Annual
Report on Form 10-K and our other reports filed with the Securities
and Exchange Commission.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160829005236/en/
Celgene CorporationPatrick E. Flanigan III, (908)
673-9969Corporate VP, Investor RelationsorBrian Gill, (908)
673-9530VP, Corporate Communications
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Feb 2024 to Mar 2024
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Mar 2023 to Mar 2024